Explore more publications!

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on November 7, 2025

R2 Recycling – MA Launches Hassle-Free Commercial Solar Panel Recycling & Statewide E-Waste Pickup
Cultural Survival Is at COP30 to Ensure Indigenous Rights Are Part of the Climate Solution
VERDE HYDROGEN Achieves Breakthrough in Anion Exchange Membrane (AEM) Technology for Green Hydrogen
KissFromItaly Celebrates 10 Years of Success with Viator — Leading the Way in Private Tours Across Italy
Creatio Announces No-Code Days Florida 2026: Agentic Leadership, the Premier Event for Leaders Driving AI Transformation
The Art of the Possible: All the Things mEinstein Can Do — That’s What mE Is
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Spyre Therapeutics Announces Grants of Inducement Awards
Harwich’s Trusted Destination for Selling Jewelry and Gold
Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at SITC 2025 40th Anniversary Annual Meeting
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
Wave Life Sciences to Present at Upcoming Investor Conferences

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions